| 0 |
PRODUCT GEL FORMATION |
36 |
0.2951 |
| 1 |
CORONARY BYPASS THROMBOSIS |
13 |
0.2766 |
| 2 |
PRODUCT DEPOSIT |
325 |
0.2085 |
| 3 |
PRODUCT WITH QUALITY ISSUE ADMINISTERED |
63 |
0.1413 |
| 4 |
CARDIAC VALVE FIBROELASTOMA |
5 |
0.1282 |
| 5 |
METAPLASIA |
34 |
0.0720 |
| 6 |
PERFORMANCE ENHANCING PRODUCT USE |
5 |
0.0505 |
| 7 |
POLYCYTHAEMIA |
82 |
0.0397 |
| 8 |
TESTICULAR FAILURE |
5 |
0.0365 |
| 9 |
LIQUID PRODUCT PHYSICAL ISSUE |
255 |
0.0349 |
| 10 |
BLOOD TESTOSTERONE INCREASED |
73 |
0.0339 |
| 11 |
SUSPECTED PRODUCT TAMPERING |
19 |
0.0339 |
| 12 |
SECONDARY HYPOGONADISM |
11 |
0.0333 |
| 13 |
EXPOSURE TO UNSPECIFIED AGENT |
6 |
0.0306 |
| 14 |
HYPOGONADISM MALE |
7 |
0.0302 |
| 15 |
ISCHAEMIA |
127 |
0.0276 |
| 16 |
PRODUCT CLOSURE ISSUE |
15 |
0.0269 |
| 17 |
OESTRADIOL INCREASED |
7 |
0.0233 |
| 18 |
POOR QUALITY PRODUCT ADMINISTERED |
244 |
0.0231 |
| 19 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
47 |
0.0209 |
| 20 |
BLOOD TESTOSTERONE ABNORMAL |
23 |
0.0208 |
| 21 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
115 |
0.0205 |
| 22 |
INFARCTION |
133 |
0.0194 |
| 23 |
BLOOD TESTOSTERONE DECREASED |
125 |
0.0183 |
| 24 |
HAEMATOCRIT INCREASED |
40 |
0.0175 |
| 25 |
HEPATIC ADENOMA |
9 |
0.0174 |
| 26 |
BLOOD OESTROGEN INCREASED |
10 |
0.0170 |
| 27 |
MALABSORPTION FROM INJECTION SITE |
5 |
0.0161 |
| 28 |
HYPOGONADISM |
16 |
0.0158 |
| 29 |
PRODUCT ADMINISTERED BY WRONG PERSON |
6 |
0.0157 |
| 30 |
POLYCYTHAEMIA VERA |
12 |
0.0147 |
| 31 |
HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION |
5 |
0.0139 |
| 32 |
MUSCLE MASS |
6 |
0.0133 |
| 33 |
SUSPECTED PRODUCT CONTAMINATION |
12 |
0.0118 |
| 34 |
TESTICULAR ATROPHY |
10 |
0.0115 |
| 35 |
ANDROGEN DEFICIENCY |
4 |
0.0114 |
| 36 |
MARITAL PROBLEM |
6 |
0.0111 |
| 37 |
CARDIAC VENTRICULAR THROMBOSIS |
14 |
0.0108 |
| 38 |
PRODUCT CONTAMINATION PHYSICAL |
26 |
0.0102 |
| 39 |
BLOOD VISCOSITY INCREASED |
6 |
0.0099 |
| 40 |
QUALITY OF LIFE DECREASED |
129 |
0.0096 |
| 41 |
DEEP VEIN THROMBOSIS |
622 |
0.0096 |
| 42 |
PRODUCT TAMPERING |
17 |
0.0095 |
| 43 |
INSULIN-LIKE GROWTH FACTOR DECREASED |
5 |
0.0095 |
| 44 |
CARDIOVASCULAR DISORDER |
225 |
0.0089 |
| 45 |
POOR QUALITY DRUG ADMINISTERED |
57 |
0.0088 |
| 46 |
CORONARY ARTERY THROMBOSIS |
16 |
0.0079 |
| 47 |
THROMBOPHLEBITIS SUPERFICIAL |
24 |
0.0079 |
| 48 |
ENDOMETRIAL ADENOCARCINOMA |
5 |
0.0079 |
| 49 |
PRE-EXISTING CONDITION IMPROVED |
49 |
0.0078 |
| 50 |
ACUTE MYOCARDIAL INFARCTION |
231 |
0.0078 |
| 51 |
PROSTATE INFECTION |
7 |
0.0073 |
| 52 |
ESSENTIAL TREMOR |
8 |
0.0072 |
| 53 |
PROSTATIC DISORDER |
39 |
0.0071 |
| 54 |
PHYSICAL DISABILITY |
31 |
0.0070 |
| 55 |
TESTICULAR DISORDER |
7 |
0.0070 |
| 56 |
RED BLOOD CELL COUNT INCREASED |
19 |
0.0069 |
| 57 |
BONE DEMINERALISATION |
7 |
0.0066 |
| 58 |
HAEMOGLOBIN INCREASED |
30 |
0.0066 |
| 59 |
INJECTION SITE INFECTION |
21 |
0.0064 |
| 60 |
PRODUCT ADMINISTRATION INTERRUPTED |
50 |
0.0064 |
| 61 |
PULMONARY INFARCTION |
15 |
0.0063 |
| 62 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
9 |
0.0063 |
| 63 |
HYPERCOAGULATION |
12 |
0.0063 |
| 64 |
RECALLED PRODUCT ADMINISTERED |
60 |
0.0063 |
| 65 |
PRODUCT COLOUR ISSUE |
32 |
0.0062 |
| 66 |
ECONOMIC PROBLEM |
92 |
0.0061 |
| 67 |
DILATED CARDIOMYOPATHY |
6 |
0.0059 |
| 68 |
PULMONARY EMBOLISM |
558 |
0.0059 |
| 69 |
PERIPHERAL ARTERY THROMBOSIS |
8 |
0.0057 |
| 70 |
HEART INJURY |
14 |
0.0056 |
| 71 |
EMBOLISM VENOUS |
17 |
0.0056 |
| 72 |
MYOCARDIAL INFARCTION |
949 |
0.0054 |
| 73 |
PRODUCT CONTAMINATION |
19 |
0.0053 |
| 74 |
PARTNER STRESS |
5 |
0.0052 |
| 75 |
PRODUCT CONTAINER SEAL ISSUE |
9 |
0.0052 |
| 76 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
6 |
0.0052 |
| 77 |
ESSENTIAL HYPERTENSION |
9 |
0.0049 |
| 78 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
6 |
0.0048 |
| 79 |
HYPOTHALAMO-PITUITARY DISORDER |
7 |
0.0048 |
| 80 |
CORONARY ARTERY DISEASE |
141 |
0.0047 |
| 81 |
SOCIAL PROBLEM |
19 |
0.0046 |
| 82 |
AORTIC THROMBOSIS |
5 |
0.0043 |
| 83 |
THROMBOSIS |
347 |
0.0043 |
| 84 |
EPIDIDYMITIS |
5 |
0.0043 |
| 85 |
BENIGN PROSTATIC HYPERPLASIA |
22 |
0.0043 |
| 86 |
ISCHAEMIC CARDIOMYOPATHY |
13 |
0.0042 |
| 87 |
ACUTE LUNG INJURY |
5 |
0.0042 |
| 88 |
PRODUCT CONTAMINATION MICROBIAL |
5 |
0.0042 |
| 89 |
PRODUCT ADMINISTRATION ERROR |
83 |
0.0041 |
| 90 |
NASAL SEPTUM DEVIATION |
8 |
0.0041 |
| 91 |
PRIAPISM |
14 |
0.0041 |
| 92 |
CEREBROVASCULAR ACCIDENT |
685 |
0.0040 |
| 93 |
INJECTION SITE INFLAMMATION |
20 |
0.0040 |
| 94 |
CAROTID ARTERY DISEASE |
5 |
0.0039 |
| 95 |
BRAIN STEM INFARCTION |
4 |
0.0039 |
| 96 |
SLEEP APNOEA SYNDROME |
72 |
0.0038 |
| 97 |
INJECTION SITE CELLULITIS |
7 |
0.0038 |
| 98 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
5 |
0.0037 |
| 99 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
38 |
0.0036 |
| 100 |
CHRONIC FATIGUE SYNDROME |
5 |
0.0036 |
| 101 |
CARBON DIOXIDE DECREASED |
4 |
0.0035 |
| 102 |
ADMINISTRATION SITE PAIN |
4 |
0.0035 |
| 103 |
RECALLED PRODUCT |
6 |
0.0035 |
| 104 |
RENAL INFARCT |
5 |
0.0035 |
| 105 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
5 |
0.0034 |
| 106 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
62 |
0.0034 |
| 107 |
LOSS OF EMPLOYMENT |
10 |
0.0033 |
| 108 |
ANHEDONIA |
86 |
0.0033 |
| 109 |
INTRACARDIAC THROMBUS |
10 |
0.0033 |
| 110 |
TRANSIENT ISCHAEMIC ATTACK |
104 |
0.0031 |
| 111 |
ABDOMINAL OPERATION |
4 |
0.0031 |
| 112 |
ANGINA UNSTABLE |
20 |
0.0031 |
| 113 |
PROSTATOMEGALY |
12 |
0.0031 |
| 114 |
SUSPECTED COUNTERFEIT PRODUCT |
12 |
0.0030 |
| 115 |
INJECTION RELATED REACTION |
5 |
0.0030 |
| 116 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
60 |
0.0030 |
| 117 |
POST-TRAUMATIC STRESS DISORDER |
20 |
0.0030 |
| 118 |
LIBIDO INCREASED |
6 |
0.0030 |
| 119 |
CEREBELLAR INFARCTION |
5 |
0.0030 |
| 120 |
CARBON DIOXIDE INCREASED |
4 |
0.0029 |
| 121 |
SUDDEN CARDIAC DEATH |
10 |
0.0029 |
| 122 |
LACUNAR INFARCTION |
7 |
0.0029 |
| 123 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
16 |
0.0029 |
| 124 |
INTRACRANIAL PRESSURE INCREASED |
16 |
0.0029 |
| 125 |
HORMONE LEVEL ABNORMAL |
14 |
0.0029 |
| 126 |
CATAPLEXY |
4 |
0.0028 |
| 127 |
RETINAL ARTERY OCCLUSION |
7 |
0.0028 |
| 128 |
HEMIPLEGIA |
23 |
0.0028 |
| 129 |
SUSPECTED PRODUCT QUALITY ISSUE |
5 |
0.0027 |
| 130 |
ERECTILE DYSFUNCTION |
70 |
0.0027 |
| 131 |
BRAIN INJURY |
27 |
0.0027 |
| 132 |
ISCHAEMIC STROKE |
48 |
0.0027 |
| 133 |
NARCOLEPSY |
5 |
0.0026 |
| 134 |
SNORING |
10 |
0.0026 |
| 135 |
PROSTATITIS |
8 |
0.0026 |
| 136 |
HAEMANGIOMA |
6 |
0.0026 |
| 137 |
AORTIC STENOSIS |
9 |
0.0026 |
| 138 |
CARDIAC FAILURE CONGESTIVE |
204 |
0.0025 |
| 139 |
WHEELCHAIR USER |
11 |
0.0025 |
| 140 |
CEREBRAL THROMBOSIS |
7 |
0.0025 |
| 141 |
RENAL HAEMORRHAGE |
5 |
0.0025 |
| 142 |
ACUTE CORONARY SYNDROME |
20 |
0.0024 |
| 143 |
INJECTION SITE ABSCESS |
6 |
0.0024 |
| 144 |
EMBOLISM |
20 |
0.0024 |
| 145 |
CEREBROVASCULAR DISORDER |
7 |
0.0023 |
| 146 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
6 |
0.0023 |
| 147 |
THROMBOPHLEBITIS |
8 |
0.0023 |
| 148 |
FAMILY STRESS |
7 |
0.0023 |
| 149 |
IMPAIRED WORK ABILITY |
48 |
0.0022 |
| 150 |
FEAR OF DEATH |
5 |
0.0022 |
| 151 |
SPINAL FUSION SURGERY |
9 |
0.0022 |
| 152 |
RED CELL DISTRIBUTION WIDTH INCREASED |
9 |
0.0022 |
| 153 |
NECK SURGERY |
5 |
0.0021 |
| 154 |
SOMNAMBULISM |
14 |
0.0021 |
| 155 |
DECREASED ACTIVITY |
23 |
0.0021 |
| 156 |
WALKING AID USER |
14 |
0.0021 |
| 157 |
CARDIAC FAILURE ACUTE |
14 |
0.0021 |
| 158 |
HIGH DENSITY LIPOPROTEIN DECREASED |
7 |
0.0021 |
| 159 |
INJECTION SITE NODULE |
23 |
0.0021 |
| 160 |
ADRENAL DISORDER |
4 |
0.0021 |
| 161 |
ARTERIAL THROMBOSIS |
4 |
0.0021 |
| 162 |
SKIN ODOUR ABNORMAL |
8 |
0.0020 |
| 163 |
CARDIOMEGALY |
25 |
0.0020 |
| 164 |
HAIR GROWTH ABNORMAL |
14 |
0.0020 |
| 165 |
ATRIAL FLUTTER |
16 |
0.0020 |
| 166 |
CAROTID ARTERY STENOSIS |
7 |
0.0020 |
| 167 |
LOSS OF LIBIDO |
18 |
0.0020 |
| 168 |
CORONARY ARTERY STENOSIS |
10 |
0.0020 |
| 169 |
SEASONAL ALLERGY |
28 |
0.0020 |
| 170 |
DYSGRAPHIA |
13 |
0.0020 |
| 171 |
ARTERIOSCLEROSIS CORONARY ARTERY |
13 |
0.0020 |
| 172 |
TESTICULAR PAIN |
6 |
0.0019 |
| 173 |
AUTOIMMUNE THYROIDITIS |
7 |
0.0018 |
| 174 |
ANORGASMIA |
5 |
0.0018 |
| 175 |
PRODUCT USE COMPLAINT |
29 |
0.0018 |
| 176 |
CARDIOMYOPATHY |
27 |
0.0018 |
| 177 |
ENDOMETRIAL CANCER |
4 |
0.0018 |
| 178 |
CHOLESTATIC LIVER INJURY |
4 |
0.0018 |
| 179 |
PAPILLOEDEMA |
8 |
0.0018 |
| 180 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
8 |
0.0018 |
| 181 |
INJECTION SITE MASS |
64 |
0.0017 |
| 182 |
MUSCLE CONTRACTIONS INVOLUNTARY |
6 |
0.0017 |
| 183 |
HANGOVER |
6 |
0.0017 |
| 184 |
ARTERIOSCLEROSIS |
16 |
0.0017 |
| 185 |
ERECTION INCREASED |
7 |
0.0017 |
| 186 |
METABOLIC ENCEPHALOPATHY |
5 |
0.0017 |
| 187 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
7 |
0.0017 |
| 188 |
ARTERIAL OCCLUSIVE DISEASE |
13 |
0.0017 |
| 189 |
OSTEOPENIA |
25 |
0.0016 |
| 190 |
INCORRECT DRUG ADMINISTRATION RATE |
7 |
0.0016 |
| 191 |
LEFT VENTRICULAR DYSFUNCTION |
11 |
0.0016 |
| 192 |
FEAR |
44 |
0.0016 |
| 193 |
DERMAL CYST |
4 |
0.0016 |
| 194 |
IMPULSIVE BEHAVIOUR |
6 |
0.0016 |
| 195 |
ONYCHOMYCOSIS |
7 |
0.0016 |
| 196 |
HYPERLIPIDAEMIA |
19 |
0.0016 |
| 197 |
INFUSION SITE PRURITUS |
5 |
0.0016 |
| 198 |
EXERCISE TOLERANCE DECREASED |
9 |
0.0016 |
| 199 |
ACUTE RESPIRATORY FAILURE |
30 |
0.0016 |
| 200 |
PORTAL VEIN THROMBOSIS |
5 |
0.0015 |
| 201 |
PRODUCT SUPPLY ISSUE |
11 |
0.0015 |
| 202 |
CARDIAC DISORDER |
144 |
0.0015 |
| 203 |
LYMPHOCYTE COUNT INCREASED |
5 |
0.0015 |
| 204 |
DECREASED INTEREST |
9 |
0.0015 |
| 205 |
ENERGY INCREASED |
9 |
0.0015 |
| 206 |
VISUAL FIELD DEFECT |
11 |
0.0015 |
| 207 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
26 |
0.0015 |
| 208 |
RENAL CYST |
12 |
0.0015 |
| 209 |
CHONDROPATHY |
4 |
0.0015 |
| 210 |
CEREBRAL INFARCTION |
36 |
0.0015 |
| 211 |
SLUGGISHNESS |
15 |
0.0015 |
| 212 |
PERIPHERAL VENOUS DISEASE |
6 |
0.0015 |
| 213 |
INJECTION SITE INDURATION |
19 |
0.0015 |
| 214 |
CARDIOGENIC SHOCK |
21 |
0.0015 |
| 215 |
SUPRAVENTRICULAR TACHYCARDIA |
14 |
0.0015 |
| 216 |
SUBCUTANEOUS ABSCESS |
7 |
0.0015 |
| 217 |
CORONARY ARTERY OCCLUSION |
20 |
0.0015 |
| 218 |
CYST |
18 |
0.0014 |
| 219 |
AORTIC ANEURYSM |
11 |
0.0014 |
| 220 |
INJECTION SITE SWELLING |
110 |
0.0014 |
| 221 |
ANGIOPATHY |
8 |
0.0014 |
| 222 |
MUSCLE ATROPHY |
18 |
0.0014 |
| 223 |
HEMIPARESIS |
24 |
0.0014 |
| 224 |
EJACULATION DISORDER |
4 |
0.0014 |
| 225 |
INTERVERTEBRAL DISC DISORDER |
6 |
0.0014 |
| 226 |
BRAIN FOG |
22 |
0.0014 |
| 227 |
PRESCRIBED OVERDOSE |
27 |
0.0014 |
| 228 |
FINE MOTOR SKILL DYSFUNCTION |
4 |
0.0014 |
| 229 |
MONOCYTE COUNT INCREASED |
5 |
0.0014 |
| 230 |
INTENTIONAL DOSE OMISSION |
39 |
0.0014 |
| 231 |
SENSORY LOSS |
11 |
0.0014 |
| 232 |
SEXUAL DYSFUNCTION |
16 |
0.0014 |
| 233 |
ANGINA PECTORIS |
39 |
0.0014 |
| 234 |
PRODUCT DOSE OMISSION ISSUE |
399 |
0.0014 |
| 235 |
SURGERY |
78 |
0.0013 |
| 236 |
CRANIOCEREBRAL INJURY |
4 |
0.0013 |
| 237 |
EMERGENCY CARE |
4 |
0.0013 |
| 238 |
INJECTION SITE WARMTH |
27 |
0.0013 |
| 239 |
PARANASAL SINUS HYPERSECRETION |
5 |
0.0013 |
| 240 |
ANXIETY |
369 |
0.0013 |
| 241 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
8 |
0.0013 |
| 242 |
OPTIC ISCHAEMIC NEUROPATHY |
5 |
0.0013 |
| 243 |
PULMONARY THROMBOSIS |
14 |
0.0013 |
| 244 |
BLOOD CREATININE DECREASED |
4 |
0.0013 |
| 245 |
BLINDNESS UNILATERAL |
18 |
0.0013 |
| 246 |
AMNESIA |
83 |
0.0013 |
| 247 |
VENOUS THROMBOSIS |
5 |
0.0013 |
| 248 |
VENTRICULAR FIBRILLATION |
14 |
0.0013 |
| 249 |
VENTRICULAR EXTRASYSTOLES |
13 |
0.0013 |
| 250 |
CELLULITIS |
63 |
0.0012 |
| 251 |
INCORRECT DRUG ADMINISTRATION DURATION |
35 |
0.0012 |
| 252 |
INJECTION SITE DISCOMFORT |
13 |
0.0012 |
| 253 |
HYPERPROLACTINAEMIA |
8 |
0.0012 |
| 254 |
VITAMIN D DEFICIENCY |
12 |
0.0012 |
| 255 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
5 |
0.0012 |
| 256 |
PERIPHERAL ISCHAEMIA |
5 |
0.0012 |
| 257 |
TRIGGER FINGER |
5 |
0.0012 |
| 258 |
GOITRE |
5 |
0.0012 |
| 259 |
PRODUCT PREPARATION ISSUE |
8 |
0.0012 |
| 260 |
SPINAL OPERATION |
15 |
0.0012 |
| 261 |
PRODUCT FORMULATION ISSUE |
8 |
0.0012 |
| 262 |
SINUS DISORDER |
24 |
0.0012 |
| 263 |
FEELING DRUNK |
9 |
0.0012 |
| 264 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
26 |
0.0012 |
| 265 |
ANXIETY DISORDER |
4 |
0.0012 |
| 266 |
BIPOLAR DISORDER |
13 |
0.0012 |
| 267 |
PRODUCT QUALITY ISSUE |
162 |
0.0012 |
| 268 |
ATRIAL FIBRILLATION |
116 |
0.0012 |
| 269 |
INTERVERTEBRAL DISC DEGENERATION |
11 |
0.0012 |
| 270 |
DRUG TOLERANCE |
6 |
0.0012 |
| 271 |
POSTOPERATIVE WOUND INFECTION |
8 |
0.0012 |
| 272 |
DYSLIPIDAEMIA |
6 |
0.0012 |
| 273 |
THERAPEUTIC RESPONSE UNEXPECTED |
53 |
0.0012 |
| 274 |
NIGHT SWEATS |
38 |
0.0012 |
| 275 |
PRODUCT LABEL ISSUE |
8 |
0.0012 |
| 276 |
TONGUE DISCOMFORT |
5 |
0.0012 |
| 277 |
IMPAIRED GASTRIC EMPTYING |
16 |
0.0012 |
| 278 |
ABSCESS LIMB |
5 |
0.0012 |
| 279 |
FACIAL PARALYSIS |
10 |
0.0012 |
| 280 |
NERVE INJURY |
13 |
0.0012 |
| 281 |
LOW DENSITY LIPOPROTEIN INCREASED |
9 |
0.0012 |
| 282 |
HEART RATE IRREGULAR |
26 |
0.0011 |
| 283 |
DRUG EFFECT LESS THAN EXPECTED |
17 |
0.0011 |
| 284 |
INCORRECT PRODUCT STORAGE |
15 |
0.0011 |
| 285 |
MELANOCYTIC NAEVUS |
5 |
0.0011 |
| 286 |
PRODUCT PHYSICAL ISSUE |
23 |
0.0011 |
| 287 |
SPINAL OSTEOARTHRITIS |
10 |
0.0011 |
| 288 |
EMBOLIC STROKE |
4 |
0.0011 |
| 289 |
TENDON RUPTURE |
14 |
0.0011 |
| 290 |
INFUSION SITE SWELLING |
7 |
0.0011 |
| 291 |
APPARENT DEATH |
4 |
0.0011 |
| 292 |
URINARY TRACT DISORDER |
5 |
0.0011 |
| 293 |
EMOTIONAL DISORDER |
34 |
0.0011 |
| 294 |
INTERVERTEBRAL DISC PROTRUSION |
24 |
0.0011 |
| 295 |
EXOSTOSIS |
10 |
0.0011 |
| 296 |
MAJOR DEPRESSION |
8 |
0.0011 |
| 297 |
CEREBRAL DISORDER |
8 |
0.0011 |
| 298 |
INJURY |
76 |
0.0011 |
| 299 |
DEPRESSION |
246 |
0.0011 |
| 300 |
ADRENAL INSUFFICIENCY |
13 |
0.0011 |
| 301 |
PRODUCT LEAKAGE |
6 |
0.0011 |
| 302 |
INFUSION SITE ERYTHEMA |
9 |
0.0011 |
| 303 |
EMOTIONAL DISTRESS |
129 |
0.0011 |
| 304 |
SQUAMOUS CELL CARCINOMA |
10 |
0.0011 |
| 305 |
INTENTIONAL PRODUCT USE ISSUE |
93 |
0.0011 |
| 306 |
TENDERNESS |
11 |
0.0011 |
| 307 |
CARDIAC VALVE DISEASE |
6 |
0.0010 |
| 308 |
BLOOD MAGNESIUM DECREASED |
9 |
0.0010 |
| 309 |
MUSCLE STRAIN |
9 |
0.0010 |
| 310 |
INJECTION SITE PAIN |
317 |
0.0010 |
| 311 |
METABOLIC DISORDER |
6 |
0.0010 |
| 312 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
73 |
0.0010 |
| 313 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
14 |
0.0010 |
| 314 |
GLUCOSE TOLERANCE IMPAIRED |
6 |
0.0010 |
| 315 |
DISABILITY |
20 |
0.0010 |
| 316 |
FOOT OPERATION |
5 |
0.0010 |
| 317 |
ANGER |
34 |
0.0010 |
| 318 |
OBSESSIVE-COMPULSIVE DISORDER |
8 |
0.0010 |
| 319 |
PRODUCT SOLUBILITY ABNORMAL |
5 |
0.0010 |
| 320 |
BONE DENSITY DECREASED |
31 |
0.0010 |
| 321 |
NOCTURIA |
12 |
0.0010 |
| 322 |
POST PROCEDURAL INFECTION |
8 |
0.0010 |
| 323 |
HYPERAESTHESIA |
8 |
0.0010 |
| 324 |
DRUG DIVERSION |
6 |
0.0010 |
| 325 |
PERIPHERAL VASCULAR DISORDER |
5 |
0.0010 |
| 326 |
BURNING SENSATION |
68 |
0.0010 |
| 327 |
PERSONALITY CHANGE |
9 |
0.0010 |
| 328 |
TRISMUS |
5 |
0.0010 |
| 329 |
AORTIC DISSECTION |
4 |
0.0010 |
| 330 |
ACCIDENTAL EXPOSURE |
4 |
0.0010 |
| 331 |
MULTIPLE INJURIES |
6 |
0.0010 |
| 332 |
TASTE DISORDER |
19 |
0.0009 |
| 333 |
VITAMIN D DECREASED |
8 |
0.0009 |
| 334 |
FOOD POISONING |
5 |
0.0009 |
| 335 |
PRODUCT CONTAINER ISSUE |
8 |
0.0009 |
| 336 |
LIMB INJURY |
25 |
0.0009 |
| 337 |
TENDON DISORDER |
6 |
0.0009 |
| 338 |
MENTAL DISORDER |
40 |
0.0009 |
| 339 |
RENAL TUBULAR NECROSIS |
9 |
0.0009 |
| 340 |
DRUG DISPENSING ERROR |
14 |
0.0009 |
| 341 |
DIVERTICULUM INTESTINAL |
4 |
0.0009 |
| 342 |
DYSPHEMIA |
4 |
0.0009 |
| 343 |
FOOD ALLERGY |
7 |
0.0009 |
| 344 |
BURSITIS |
11 |
0.0009 |
| 345 |
HYPERKERATOSIS |
5 |
0.0009 |
| 346 |
APPETITE DISORDER |
6 |
0.0009 |
| 347 |
IMPAIRED QUALITY OF LIFE |
13 |
0.0009 |
| 348 |
PARAESTHESIA ORAL |
13 |
0.0009 |
| 349 |
MALIGNANT MELANOMA |
12 |
0.0009 |
| 350 |
GLOMERULAR FILTRATION RATE DECREASED |
11 |
0.0009 |
| 351 |
AFFECTIVE DISORDER |
7 |
0.0009 |
| 352 |
FURUNCLE |
7 |
0.0009 |
| 353 |
ABDOMINAL HERNIA |
4 |
0.0009 |
| 354 |
SCAR |
15 |
0.0009 |
| 355 |
PRODUCT USE ISSUE |
164 |
0.0009 |
| 356 |
TEMPERATURE INTOLERANCE |
9 |
0.0009 |
| 357 |
PRODUCT PRESCRIBING ISSUE |
19 |
0.0009 |
| 358 |
BUNDLE BRANCH BLOCK RIGHT |
4 |
0.0009 |
| 359 |
CORONARY ARTERY BYPASS |
5 |
0.0009 |
| 360 |
EYE OPERATION |
4 |
0.0009 |
| 361 |
NEURALGIA |
21 |
0.0009 |
| 362 |
CONJUNCTIVITIS |
16 |
0.0009 |
| 363 |
HUNGER |
12 |
0.0009 |
| 364 |
BACK DISORDER |
14 |
0.0009 |
| 365 |
WEIGHT FLUCTUATION |
9 |
0.0009 |
| 366 |
PRODUCT LABEL CONFUSION |
5 |
0.0009 |
| 367 |
HICCUPS |
7 |
0.0009 |
| 368 |
COLD SWEAT |
15 |
0.0009 |
| 369 |
UPPER-AIRWAY COUGH SYNDROME |
7 |
0.0008 |
| 370 |
BLOOD PROLACTIN INCREASED |
4 |
0.0008 |
| 371 |
CHRONIC KIDNEY DISEASE |
64 |
0.0008 |
| 372 |
IMMUNE SYSTEM DISORDER |
11 |
0.0008 |
| 373 |
LETHARGY |
48 |
0.0008 |
| 374 |
AFFECT LABILITY |
8 |
0.0008 |
| 375 |
BACK INJURY |
9 |
0.0008 |
| 376 |
RESTLESS LEGS SYNDROME |
15 |
0.0008 |
| 377 |
APATHY |
12 |
0.0008 |
| 378 |
TENSION |
5 |
0.0008 |
| 379 |
DRUG EFFECT DECREASED |
44 |
0.0008 |
| 380 |
SINUS CONGESTION |
11 |
0.0008 |
| 381 |
MUSCLE SPASTICITY |
10 |
0.0008 |
| 382 |
KNEE OPERATION |
8 |
0.0008 |
| 383 |
MENISCUS INJURY |
5 |
0.0008 |
| 384 |
ABDOMINAL TENDERNESS |
4 |
0.0008 |
| 385 |
ANEURYSM |
4 |
0.0008 |
| 386 |
SKIN INFECTION |
9 |
0.0008 |
| 387 |
OSTEOPOROSIS |
33 |
0.0008 |
| 388 |
FLUID INTAKE REDUCED |
4 |
0.0008 |
| 389 |
PAIN |
491 |
0.0008 |
| 390 |
CHEST PAIN |
148 |
0.0008 |
| 391 |
EMPHYSEMA |
8 |
0.0008 |
| 392 |
PHOTOPSIA |
5 |
0.0008 |
| 393 |
MYOCARDIAL ISCHAEMIA |
9 |
0.0008 |
| 394 |
DYSPHORIA |
4 |
0.0008 |
| 395 |
CORONARY ARTERIAL STENT INSERTION |
4 |
0.0008 |
| 396 |
VENTRICULAR TACHYCARDIA |
13 |
0.0008 |
| 397 |
THIRST |
14 |
0.0008 |
| 398 |
EXPIRED PRODUCT ADMINISTERED |
26 |
0.0008 |
| 399 |
PRODUCT SUBSTITUTION ISSUE |
45 |
0.0008 |
| 400 |
ENDOCARDITIS |
4 |
0.0008 |
| 401 |
INITIAL INSOMNIA |
8 |
0.0008 |
| 402 |
CEREBRAL ISCHAEMIA |
4 |
0.0008 |
| 403 |
ATRIOVENTRICULAR BLOCK |
6 |
0.0008 |
| 404 |
INFUSION SITE PAIN |
10 |
0.0008 |
| 405 |
CONCUSSION |
6 |
0.0008 |
| 406 |
OROPHARYNGEAL DISCOMFORT |
7 |
0.0008 |
| 407 |
HYPERSOMNIA |
22 |
0.0008 |
| 408 |
BALANCE DISORDER |
66 |
0.0008 |
| 409 |
CARDIAC ARREST |
63 |
0.0008 |
| 410 |
RETINAL DETACHMENT |
7 |
0.0008 |
| 411 |
DYSURIA |
28 |
0.0008 |
| 412 |
PARANOIA |
13 |
0.0008 |
| 413 |
OBESITY |
12 |
0.0008 |
| 414 |
THINKING ABNORMAL |
14 |
0.0008 |
| 415 |
FEELING ABNORMAL |
180 |
0.0008 |
| 416 |
BLOOD CHOLESTEROL INCREASED |
35 |
0.0008 |
| 417 |
DEFORMITY |
7 |
0.0007 |
| 418 |
GASTROINTESTINAL MOTILITY DISORDER |
4 |
0.0007 |
| 419 |
NEPHROLITHIASIS |
34 |
0.0007 |
| 420 |
MUSCLE TIGHTNESS |
12 |
0.0007 |
| 421 |
BLOOD TRIGLYCERIDES INCREASED |
13 |
0.0007 |
| 422 |
PRODUCT DOSE OMISSION |
48 |
0.0007 |
| 423 |
HYPERTENSION |
154 |
0.0007 |
| 424 |
UNDERDOSE |
53 |
0.0007 |
| 425 |
DISTURBANCE IN ATTENTION |
39 |
0.0007 |
| 426 |
DERMATITIS ATOPIC |
38 |
0.0007 |
| 427 |
INJECTION SITE DISCOLOURATION |
9 |
0.0007 |
| 428 |
HIP ARTHROPLASTY |
11 |
0.0007 |
| 429 |
PHARYNGEAL SWELLING |
7 |
0.0007 |
| 430 |
ASTHENIA |
269 |
0.0007 |
| 431 |
BLOOD CALCIUM DECREASED |
8 |
0.0007 |
| 432 |
DELUSION |
11 |
0.0007 |
| 433 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
12 |
0.0007 |
| 434 |
DIVERTICULUM |
5 |
0.0007 |
| 435 |
ROTATOR CUFF SYNDROME |
9 |
0.0007 |
| 436 |
MYOCARDITIS |
8 |
0.0007 |
| 437 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
125 |
0.0007 |
| 438 |
ROAD TRAFFIC ACCIDENT |
29 |
0.0007 |
| 439 |
HYSTERECTOMY |
6 |
0.0007 |
| 440 |
SKIN LESION |
19 |
0.0007 |
| 441 |
HYPOTHYROIDISM |
22 |
0.0007 |
| 442 |
FLUID OVERLOAD |
10 |
0.0007 |
| 443 |
MOTOR DYSFUNCTION |
7 |
0.0007 |
| 444 |
GROIN PAIN |
6 |
0.0007 |
| 445 |
FEELING COLD |
19 |
0.0007 |
| 446 |
FEELING OF BODY TEMPERATURE CHANGE |
4 |
0.0007 |
| 447 |
ORAL DISORDER |
5 |
0.0007 |
| 448 |
RIB FRACTURE |
14 |
0.0007 |
| 449 |
BLOOD IRON DECREASED |
8 |
0.0007 |
| 450 |
CARDIAC PACEMAKER INSERTION |
4 |
0.0007 |
| 451 |
INJECTION SITE ERYTHEMA |
83 |
0.0007 |
| 452 |
MANIA |
11 |
0.0007 |
| 453 |
ANAL INCONTINENCE |
6 |
0.0007 |
| 454 |
SLEEP DISORDER |
47 |
0.0007 |
| 455 |
GASTROENTERITIS VIRAL |
12 |
0.0007 |
| 456 |
SCRATCH |
7 |
0.0007 |
| 457 |
LOCALISED INFECTION |
16 |
0.0007 |
| 458 |
BODY HEIGHT DECREASED |
7 |
0.0007 |
| 459 |
INSURANCE ISSUE |
10 |
0.0007 |
| 460 |
BRAIN NEOPLASM |
6 |
0.0007 |
| 461 |
POOR QUALITY SLEEP |
14 |
0.0006 |
| 462 |
NERVE COMPRESSION |
6 |
0.0006 |
| 463 |
SPEECH DISORDER |
34 |
0.0006 |
| 464 |
THYROID DISORDER |
10 |
0.0006 |
| 465 |
MUSCULOSKELETAL CHEST PAIN |
10 |
0.0006 |
| 466 |
COORDINATION ABNORMAL |
9 |
0.0006 |
| 467 |
CARPAL TUNNEL SYNDROME |
9 |
0.0006 |
| 468 |
OESOPHAGITIS |
7 |
0.0006 |
| 469 |
HAEMORRHAGIC STROKE |
5 |
0.0006 |
| 470 |
EPSTEIN-BARR VIRUS INFECTION |
4 |
0.0006 |
| 471 |
BLINDNESS |
26 |
0.0006 |
| 472 |
FOOT FRACTURE |
12 |
0.0006 |
| 473 |
DRUG SCREEN POSITIVE |
5 |
0.0006 |
| 474 |
SPUTUM DISCOLOURED |
6 |
0.0006 |
| 475 |
BLOOD POTASSIUM DECREASED |
19 |
0.0006 |
| 476 |
NASAL DISCOMFORT |
5 |
0.0006 |
| 477 |
PARALYSIS |
9 |
0.0006 |
| 478 |
INJECTION SITE IRRITATION |
8 |
0.0006 |
| 479 |
SCIATICA |
10 |
0.0006 |
| 480 |
FATIGUE |
487 |
0.0006 |
| 481 |
SUICIDAL IDEATION |
57 |
0.0006 |
| 482 |
RHINITIS |
5 |
0.0006 |
| 483 |
FRUSTRATION TOLERANCE DECREASED |
5 |
0.0006 |
| 484 |
EXPOSURE VIA SKIN CONTACT |
16 |
0.0006 |
| 485 |
MUSCLE DISORDER |
5 |
0.0006 |
| 486 |
IMPAIRED DRIVING ABILITY |
7 |
0.0006 |
| 487 |
OSTEOARTHRITIS |
26 |
0.0006 |
| 488 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
32 |
0.0006 |
| 489 |
MICTURITION URGENCY |
7 |
0.0006 |
| 490 |
DRUG ABUSE |
51 |
0.0006 |
| 491 |
LUNG DISORDER |
30 |
0.0006 |
| 492 |
NEOPLASM |
7 |
0.0006 |
| 493 |
MULTIPLE FRACTURES |
10 |
0.0006 |
| 494 |
TOOTH INFECTION |
8 |
0.0006 |
| 495 |
UPPER RESPIRATORY TRACT INFECTION |
28 |
0.0006 |
| 496 |
PERICARDIAL EFFUSION |
14 |
0.0006 |
| 497 |
DEPRESSED MOOD |
32 |
0.0006 |
| 498 |
PULMONARY MASS |
9 |
0.0006 |
| 499 |
BONE DISORDER |
11 |
0.0006 |
| 500 |
IRRITABILITY |
36 |
0.0006 |
| 501 |
BLOOD UREA INCREASED |
10 |
0.0006 |
| 502 |
PERICARDITIS |
10 |
0.0006 |
| 503 |
INTENTIONAL PRODUCT MISUSE |
52 |
0.0006 |
| 504 |
MEMORY IMPAIRMENT |
81 |
0.0006 |
| 505 |
MIDDLE INSOMNIA |
11 |
0.0006 |
| 506 |
ABNORMAL LOSS OF WEIGHT |
4 |
0.0006 |
| 507 |
MOOD ALTERED |
16 |
0.0006 |
| 508 |
ECCHYMOSIS |
4 |
0.0006 |
| 509 |
DYSSTASIA |
17 |
0.0006 |
| 510 |
BLOOD CREATININE INCREASED |
38 |
0.0006 |
| 511 |
MUSCULOSKELETAL DISCOMFORT |
10 |
0.0006 |
| 512 |
NEUROPATHY PERIPHERAL |
55 |
0.0006 |
| 513 |
COGNITIVE DISORDER |
27 |
0.0006 |
| 514 |
DIABETES MELLITUS |
44 |
0.0006 |
| 515 |
STAPHYLOCOCCAL INFECTION |
19 |
0.0006 |
| 516 |
SINUSITIS |
59 |
0.0006 |
| 517 |
FORMICATION |
4 |
0.0006 |
| 518 |
POST PROCEDURAL COMPLICATION |
11 |
0.0006 |
| 519 |
MUSCULOSKELETAL PAIN |
30 |
0.0006 |
| 520 |
ARRHYTHMIA |
27 |
0.0006 |
| 521 |
KNEE ARTHROPLASTY |
12 |
0.0006 |
| 522 |
BLOOD TEST ABNORMAL |
8 |
0.0006 |
| 523 |
JOINT DISLOCATION |
6 |
0.0006 |
| 524 |
PHARYNGITIS |
7 |
0.0006 |
| 525 |
HAEMORRHOIDS |
11 |
0.0006 |
| 526 |
LACRIMATION INCREASED |
17 |
0.0006 |
| 527 |
JOINT INJURY |
12 |
0.0006 |
| 528 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
25 |
0.0006 |
| 529 |
GOUT |
10 |
0.0006 |
| 530 |
DISCOMFORT |
34 |
0.0006 |
| 531 |
BRONCHITIS |
41 |
0.0006 |
| 532 |
BLOOD PRESSURE ABNORMAL |
11 |
0.0006 |
| 533 |
MYALGIA |
94 |
0.0006 |
| 534 |
ANOSMIA |
8 |
0.0006 |
| 535 |
SKIN LACERATION |
6 |
0.0006 |
| 536 |
GAIT DISTURBANCE |
105 |
0.0005 |
| 537 |
HIDRADENITIS |
5 |
0.0005 |
| 538 |
GASTROINTESTINAL PAIN |
6 |
0.0005 |
| 539 |
PRODUCT USE IN UNAPPROVED INDICATION |
135 |
0.0005 |
| 540 |
TOOTH FRACTURE |
6 |
0.0005 |
| 541 |
PSYCHOMOTOR HYPERACTIVITY |
9 |
0.0005 |
| 542 |
IRON DEFICIENCY ANAEMIA |
5 |
0.0005 |
| 543 |
SKIN ULCER |
14 |
0.0005 |
| 544 |
VIRAL INFECTION |
18 |
0.0005 |
| 545 |
MENTAL STATUS CHANGES |
15 |
0.0005 |
| 546 |
ARTHROPOD BITE |
4 |
0.0005 |
| 547 |
PAIN IN EXTREMITY |
159 |
0.0005 |
| 548 |
MUSCLE SPASMS |
99 |
0.0005 |
| 549 |
BLOOD PRESSURE INCREASED |
82 |
0.0005 |
| 550 |
PRODUCT PREPARATION ERROR |
11 |
0.0005 |
| 551 |
MOOD SWINGS |
17 |
0.0005 |
| 552 |
PERIPHERAL SWELLING |
82 |
0.0005 |
| 553 |
INJECTION SITE URTICARIA |
13 |
0.0005 |
| 554 |
APHASIA |
16 |
0.0005 |
| 555 |
MOBILITY DECREASED |
38 |
0.0005 |
| 556 |
PRODUCT PACKAGING ISSUE |
5 |
0.0005 |
| 557 |
MUSCULOSKELETAL DISORDER |
10 |
0.0005 |
| 558 |
WEIGHT INCREASED |
116 |
0.0005 |
| 559 |
THROAT TIGHTNESS |
14 |
0.0005 |
| 560 |
PSORIATIC ARTHROPATHY |
21 |
0.0005 |
| 561 |
GYNAECOMASTIA |
16 |
0.0005 |
| 562 |
DIZZINESS POSTURAL |
5 |
0.0005 |
| 563 |
PRODUCT STORAGE ERROR |
45 |
0.0005 |
| 564 |
APNOEA |
4 |
0.0005 |
| 565 |
CHOKING |
10 |
0.0005 |
| 566 |
HYPOXIA |
18 |
0.0005 |
| 567 |
GASTROOESOPHAGEAL REFLUX DISEASE |
41 |
0.0005 |
| 568 |
HEAD DISCOMFORT |
9 |
0.0005 |
| 569 |
COVID-19 PNEUMONIA |
6 |
0.0005 |
| 570 |
HYPOAESTHESIA |
76 |
0.0005 |
| 571 |
FEELING HOT |
31 |
0.0005 |
| 572 |
TYPE 2 DIABETES MELLITUS |
17 |
0.0005 |
| 573 |
CHOLECYSTITIS |
6 |
0.0005 |
| 574 |
HALLUCINATION, AUDITORY |
8 |
0.0005 |
| 575 |
UNEVALUABLE EVENT |
38 |
0.0005 |
| 576 |
CARDIO-RESPIRATORY ARREST |
21 |
0.0005 |
| 577 |
MUSCULAR WEAKNESS |
57 |
0.0005 |
| 578 |
DIPLOPIA |
13 |
0.0005 |
| 579 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
24 |
0.0005 |
| 580 |
BLOOD DISORDER |
4 |
0.0005 |
| 581 |
ACUTE KIDNEY INJURY |
76 |
0.0005 |
| 582 |
COVID-19 |
87 |
0.0005 |
| 583 |
PANIC ATTACK |
18 |
0.0005 |
| 584 |
FIBROMYALGIA |
12 |
0.0005 |
| 585 |
PRESYNCOPE |
12 |
0.0005 |
| 586 |
BLOOD POTASSIUM INCREASED |
8 |
0.0005 |
| 587 |
FLUID RETENTION |
25 |
0.0005 |
| 588 |
SUBARACHNOID HAEMORRHAGE |
5 |
0.0005 |
| 589 |
INJECTION SITE RASH |
15 |
0.0005 |
| 590 |
SMALL INTESTINAL OBSTRUCTION |
6 |
0.0005 |
| 591 |
ESCHERICHIA INFECTION |
4 |
0.0005 |
| 592 |
CARDIAC FAILURE |
39 |
0.0005 |
| 593 |
ILLNESS |
50 |
0.0005 |
| 594 |
INFECTION |
70 |
0.0005 |
| 595 |
ARTHRITIS |
38 |
0.0005 |
| 596 |
ILEUS |
6 |
0.0005 |
| 597 |
RENAL FAILURE |
64 |
0.0005 |
| 598 |
MIGRAINE |
46 |
0.0005 |
| 599 |
EOSINOPHIL COUNT INCREASED |
4 |
0.0005 |
| 600 |
SECRETION DISCHARGE |
6 |
0.0005 |
| 601 |
TINNITUS |
22 |
0.0005 |
| 602 |
PHOTOPHOBIA |
9 |
0.0005 |
| 603 |
BLOOD SODIUM DECREASED |
9 |
0.0005 |
| 604 |
NASAL CONGESTION |
28 |
0.0005 |
| 605 |
DRUG INEFFECTIVE |
625 |
0.0005 |
| 606 |
HEAD INJURY |
15 |
0.0005 |
| 607 |
BACK PAIN |
110 |
0.0005 |
| 608 |
SKIN HAEMORRHAGE |
7 |
0.0005 |
| 609 |
RENAL DISORDER |
22 |
0.0005 |
| 610 |
SOMNOLENCE |
95 |
0.0005 |
| 611 |
WEIGHT DECREASED |
131 |
0.0005 |
| 612 |
PULMONARY FIBROSIS |
9 |
0.0005 |
| 613 |
DIVERTICULITIS |
13 |
0.0005 |
| 614 |
GLAUCOMA |
9 |
0.0005 |
| 615 |
HAEMATOMA |
12 |
0.0005 |
| 616 |
RESPIRATORY TRACT INFECTION |
12 |
0.0005 |
| 617 |
AGGRESSION |
23 |
0.0005 |
| 618 |
PRODUCT DISPENSING ERROR |
10 |
0.0005 |
| 619 |
DEAFNESS |
12 |
0.0005 |
| 620 |
KIDNEY INFECTION |
9 |
0.0005 |
| 621 |
RASH MACULAR |
16 |
0.0005 |
| 622 |
OSTEONECROSIS |
15 |
0.0005 |
| 623 |
BLOOD CALCIUM INCREASED |
4 |
0.0005 |
| 624 |
PULMONARY CONGESTION |
6 |
0.0005 |
| 625 |
MENTAL IMPAIRMENT |
11 |
0.0005 |
| 626 |
ANKLE FRACTURE |
7 |
0.0005 |
| 627 |
DENTAL CARIES |
5 |
0.0005 |
| 628 |
LYMPHADENOPATHY |
16 |
0.0005 |
| 629 |
ASPARTATE AMINOTRANSFERASE INCREASED |
24 |
0.0005 |
| 630 |
FOOT DEFORMITY |
5 |
0.0005 |
| 631 |
INJECTION SITE REACTION |
31 |
0.0005 |
| 632 |
DYSPNOEA |
254 |
0.0004 |
| 633 |
BASAL CELL CARCINOMA |
7 |
0.0004 |
| 634 |
MALNUTRITION |
5 |
0.0004 |
| 635 |
CEREBRAL HAEMORRHAGE |
16 |
0.0004 |
| 636 |
GASTROINTESTINAL INFECTION |
4 |
0.0004 |
| 637 |
BLOOD BILIRUBIN INCREASED |
12 |
0.0004 |
| 638 |
EYE PAIN |
25 |
0.0004 |
| 639 |
OEDEMA |
24 |
0.0004 |
| 640 |
INCORRECT DOSE ADMINISTERED |
101 |
0.0004 |
| 641 |
OSTEOMYELITIS |
8 |
0.0004 |
| 642 |
MITRAL VALVE INCOMPETENCE |
5 |
0.0004 |
| 643 |
ULCER |
7 |
0.0004 |
| 644 |
ABSCESS |
7 |
0.0004 |
| 645 |
END STAGE RENAL DISEASE |
8 |
0.0004 |
| 646 |
DERMATITIS CONTACT |
5 |
0.0004 |
| 647 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
11 |
0.0004 |
| 648 |
ACNE |
33 |
0.0004 |
| 649 |
COUGH |
121 |
0.0004 |
| 650 |
HEPATIC STEATOSIS |
8 |
0.0004 |
| 651 |
NECK PAIN |
24 |
0.0004 |
| 652 |
WITHDRAWAL SYNDROME |
18 |
0.0004 |
| 653 |
INSOMNIA |
114 |
0.0004 |
| 654 |
SPLENOMEGALY |
5 |
0.0004 |
| 655 |
FLANK PAIN |
4 |
0.0004 |
| 656 |
HOT FLUSH |
32 |
0.0004 |
| 657 |
PULMONARY OEDEMA |
19 |
0.0004 |
| 658 |
PRODUCT DOSE OMISSION IN ERROR |
12 |
0.0004 |
| 659 |
THERAPEUTIC RESPONSE SHORTENED |
14 |
0.0004 |
| 660 |
SYNCOPE |
42 |
0.0004 |
| 661 |
HYPERHIDROSIS |
54 |
0.0004 |
| 662 |
SUBDURAL HAEMATOMA |
6 |
0.0004 |
| 663 |
PRODUCTIVE COUGH |
20 |
0.0004 |
| 664 |
ACCIDENT |
5 |
0.0004 |
| 665 |
INCREASED APPETITE |
8 |
0.0004 |
| 666 |
WRIST FRACTURE |
5 |
0.0004 |
| 667 |
CANDIDA INFECTION |
7 |
0.0004 |
| 668 |
HERNIA |
8 |
0.0004 |
| 669 |
HYPOKINESIA |
6 |
0.0004 |
| 670 |
INFLUENZA |
46 |
0.0004 |
| 671 |
AUTOIMMUNE DISORDER |
4 |
0.0004 |
| 672 |
DYSPHONIA |
24 |
0.0004 |
| 673 |
CHEST DISCOMFORT |
42 |
0.0004 |
| 674 |
HYPERSENSITIVITY |
76 |
0.0004 |
| 675 |
POLLAKIURIA |
17 |
0.0004 |
| 676 |
SEIZURE |
47 |
0.0004 |
| 677 |
HYPERCALCAEMIA |
5 |
0.0004 |
| 678 |
MOVEMENT DISORDER |
13 |
0.0004 |
| 679 |
TOOTH DISORDER |
9 |
0.0004 |
| 680 |
ABASIA |
10 |
0.0004 |
| 681 |
ORTHOSTATIC HYPOTENSION |
7 |
0.0004 |
| 682 |
ORAL PAIN |
9 |
0.0004 |
| 683 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
22 |
0.0004 |
| 684 |
THERAPY NON-RESPONDER |
18 |
0.0004 |
| 685 |
HEADACHE |
251 |
0.0004 |
| 686 |
DISEASE RECURRENCE |
19 |
0.0004 |
| 687 |
ABNORMAL DREAMS |
11 |
0.0004 |
| 688 |
INTESTINAL OBSTRUCTION |
15 |
0.0004 |
| 689 |
DEHYDRATION |
53 |
0.0004 |
| 690 |
PANCREATITIS |
21 |
0.0004 |
| 691 |
CONFUSIONAL STATE |
64 |
0.0004 |
| 692 |
BRAIN OEDEMA |
5 |
0.0004 |
| 693 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
7 |
0.0004 |
| 694 |
RECTAL HAEMORRHAGE |
17 |
0.0004 |
| 695 |
FEEDING DISORDER |
8 |
0.0004 |
| 696 |
PLEURAL EFFUSION |
24 |
0.0004 |
| 697 |
VERTIGO |
24 |
0.0004 |
| 698 |
RENAL IMPAIRMENT |
33 |
0.0004 |
| 699 |
URINARY RETENTION |
13 |
0.0004 |
| 700 |
INJECTION SITE PRURITUS |
26 |
0.0004 |
| 701 |
DYSPEPSIA |
38 |
0.0004 |
| 702 |
DRUG EFFECT INCOMPLETE |
14 |
0.0004 |
| 703 |
PROSTATE CANCER |
31 |
0.0004 |
| 704 |
RHABDOMYOLYSIS |
16 |
0.0004 |
| 705 |
SEDATION |
10 |
0.0004 |
| 706 |
BEDRIDDEN |
5 |
0.0004 |
| 707 |
ANAPHYLACTIC REACTION |
21 |
0.0004 |
| 708 |
ARTHRALGIA |
158 |
0.0004 |
| 709 |
ORAL CANDIDIASIS |
5 |
0.0004 |
| 710 |
HAEMATURIA |
13 |
0.0004 |
| 711 |
SARS-COV-2 TEST POSITIVE |
5 |
0.0004 |
| 712 |
NEEDLE ISSUE |
11 |
0.0004 |
| 713 |
RESPIRATORY TRACT CONGESTION |
6 |
0.0004 |
| 714 |
CLOSTRIDIUM DIFFICILE COLITIS |
4 |
0.0004 |
| 715 |
EAR INFECTION |
10 |
0.0004 |
| 716 |
EYE HAEMORRHAGE |
5 |
0.0004 |
| 717 |
SWELLING |
35 |
0.0004 |
| 718 |
TUBULOINTERSTITIAL NEPHRITIS |
7 |
0.0004 |
| 719 |
CONDITION AGGRAVATED |
113 |
0.0004 |
| 720 |
SKIN CANCER |
8 |
0.0004 |
| 721 |
VISION BLURRED |
51 |
0.0004 |
| 722 |
URINARY INCONTINENCE |
11 |
0.0004 |
| 723 |
RENAL INJURY |
11 |
0.0004 |
| 724 |
FEELING JITTERY |
7 |
0.0004 |
| 725 |
CHOLELITHIASIS |
12 |
0.0004 |
| 726 |
ABDOMINAL DISTENSION |
38 |
0.0004 |
| 727 |
ABDOMINAL DISCOMFORT |
61 |
0.0004 |
| 728 |
APPLICATION SITE PAIN |
8 |
0.0004 |
| 729 |
TREMOR |
60 |
0.0004 |
| 730 |
BLOOD GLUCOSE INCREASED |
68 |
0.0004 |
| 731 |
OFF LABEL USE |
316 |
0.0004 |
| 732 |
ORAL DISCOMFORT |
5 |
0.0004 |
| 733 |
PALPITATIONS |
42 |
0.0004 |
| 734 |
PNEUMONIA |
116 |
0.0004 |
| 735 |
MASS |
5 |
0.0004 |
| 736 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0004 |
| 737 |
FISTULA |
4 |
0.0004 |
| 738 |
PRODUCT COMPLAINT |
9 |
0.0004 |
| 739 |
CHROMATURIA |
8 |
0.0004 |
| 740 |
EYE INFECTION |
4 |
0.0004 |
| 741 |
PAIN IN JAW |
10 |
0.0004 |
| 742 |
NERVOUS SYSTEM DISORDER |
11 |
0.0004 |
| 743 |
LOSS OF CONSCIOUSNESS |
45 |
0.0004 |
| 744 |
INJECTION SITE BRUISING |
28 |
0.0004 |
| 745 |
THERAPY INTERRUPTED |
25 |
0.0003 |
| 746 |
PARAESTHESIA |
55 |
0.0003 |
| 747 |
EYE SWELLING |
13 |
0.0003 |
| 748 |
FALL |
116 |
0.0003 |
| 749 |
EYE IRRITATION |
20 |
0.0003 |
| 750 |
ACCIDENTAL UNDERDOSE |
5 |
0.0003 |
| 751 |
NIGHTMARE |
12 |
0.0003 |
| 752 |
THERAPEUTIC RESPONSE DECREASED |
21 |
0.0003 |
| 753 |
DYSARTHRIA |
13 |
0.0003 |
| 754 |
DYSPNOEA EXERTIONAL |
13 |
0.0003 |
| 755 |
INJECTION SITE HAEMATOMA |
5 |
0.0003 |
| 756 |
HYPERKALAEMIA |
12 |
0.0003 |
| 757 |
AMENORRHOEA |
6 |
0.0003 |
| 758 |
LYMPHOCYTE COUNT DECREASED |
6 |
0.0003 |
| 759 |
TACHYCARDIA |
30 |
0.0003 |
| 760 |
TOOTH LOSS |
7 |
0.0003 |
| 761 |
OCULAR HYPERAEMIA |
16 |
0.0003 |
| 762 |
ATAXIA |
4 |
0.0003 |
| 763 |
NASOPHARYNGITIS |
62 |
0.0003 |
| 764 |
PULMONARY HYPERTENSION |
7 |
0.0003 |
| 765 |
BONE LOSS |
5 |
0.0003 |
| 766 |
HYPOAESTHESIA ORAL |
5 |
0.0003 |
| 767 |
LEUKOCYTOSIS |
6 |
0.0003 |
| 768 |
PNEUMONITIS |
9 |
0.0003 |
| 769 |
CONSTIPATION |
72 |
0.0003 |
| 770 |
SKIN DISORDER |
11 |
0.0003 |
| 771 |
DIZZINESS |
164 |
0.0003 |
| 772 |
INFLUENZA LIKE ILLNESS |
27 |
0.0003 |
| 773 |
DYSPHAGIA |
31 |
0.0003 |
| 774 |
MALAISE |
143 |
0.0003 |
| 775 |
DRUG ADMINISTRATION ERROR |
10 |
0.0003 |
| 776 |
ENCEPHALOPATHY |
8 |
0.0003 |
| 777 |
ALANINE AMINOTRANSFERASE INCREASED |
20 |
0.0003 |
| 778 |
BONE PAIN |
19 |
0.0003 |
| 779 |
TENDONITIS |
5 |
0.0003 |
| 780 |
BACTERIAL INFECTION |
6 |
0.0003 |
| 781 |
EPISTAXIS |
24 |
0.0003 |
| 782 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
65 |
0.0003 |
| 783 |
BLISTER |
18 |
0.0003 |
| 784 |
PNEUMONIA ASPIRATION |
8 |
0.0003 |
| 785 |
FRACTURE |
6 |
0.0003 |
| 786 |
FLUSHING |
32 |
0.0003 |
| 787 |
VISUAL IMPAIRMENT |
39 |
0.0003 |
| 788 |
AGITATION |
23 |
0.0003 |
| 789 |
HEART RATE INCREASED |
31 |
0.0003 |
| 790 |
WHITE BLOOD CELL COUNT INCREASED |
12 |
0.0003 |
| 791 |
SENSORY DISTURBANCE |
5 |
0.0003 |
| 792 |
ACCIDENTAL EXPOSURE TO PRODUCT |
32 |
0.0003 |
| 793 |
DECREASED APPETITE |
72 |
0.0003 |
| 794 |
DYSGEUSIA |
23 |
0.0003 |
| 795 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
22 |
0.0003 |
| 796 |
PHARMACEUTICAL PRODUCT COMPLAINT |
8 |
0.0003 |
| 797 |
PLASMA CELL MYELOMA |
12 |
0.0003 |
| 798 |
RASH |
134 |
0.0003 |
| 799 |
SKIN FISSURES |
6 |
0.0003 |
| 800 |
NERVOUSNESS |
16 |
0.0003 |
| 801 |
HOSPITALISATION |
47 |
0.0003 |
| 802 |
ARTHROPATHY |
17 |
0.0003 |
| 803 |
ECZEMA |
16 |
0.0003 |
| 804 |
LABORATORY TEST ABNORMAL |
9 |
0.0003 |
| 805 |
SKIN DISCOLOURATION |
14 |
0.0003 |
| 806 |
URTICARIA |
51 |
0.0003 |
| 807 |
MUSCLE TWITCHING |
7 |
0.0003 |
| 808 |
WHEEZING |
18 |
0.0003 |
| 809 |
HYPOKALAEMIA |
14 |
0.0003 |
| 810 |
ABNORMAL BEHAVIOUR |
12 |
0.0003 |
| 811 |
GENERAL PHYSICAL HEALTH DETERIORATION |
35 |
0.0003 |
| 812 |
OXYGEN SATURATION DECREASED |
17 |
0.0003 |
| 813 |
HYPOACUSIS |
13 |
0.0003 |
| 814 |
UPPER LIMB FRACTURE |
6 |
0.0003 |
| 815 |
SPINAL FRACTURE |
6 |
0.0003 |
| 816 |
FULL BLOOD COUNT DECREASED |
6 |
0.0003 |
| 817 |
CONTRAINDICATED PRODUCT ADMINISTERED |
9 |
0.0003 |
| 818 |
ILL-DEFINED DISORDER |
18 |
0.0003 |
| 819 |
PRODUCT PRESCRIBING ERROR |
7 |
0.0003 |
| 820 |
TREATMENT NONCOMPLIANCE |
16 |
0.0003 |
| 821 |
CONTUSION |
28 |
0.0003 |
| 822 |
DRUG DOSE OMISSION |
48 |
0.0003 |
| 823 |
ADVERSE DRUG REACTION |
26 |
0.0003 |
| 824 |
PROCEDURAL PAIN |
8 |
0.0003 |
| 825 |
RESPIRATORY FAILURE |
21 |
0.0003 |
| 826 |
SEPSIS |
32 |
0.0003 |
| 827 |
APHONIA |
4 |
0.0003 |
| 828 |
DERMATITIS |
6 |
0.0003 |
| 829 |
MUSCULOSKELETAL STIFFNESS |
25 |
0.0003 |
| 830 |
HEART RATE DECREASED |
10 |
0.0003 |
| 831 |
DRY MOUTH |
23 |
0.0003 |
| 832 |
ASTHMA |
32 |
0.0003 |
| 833 |
DIALYSIS |
4 |
0.0003 |
| 834 |
GALLBLADDER DISORDER |
5 |
0.0003 |
| 835 |
IRRITABLE BOWEL SYNDROME |
6 |
0.0003 |
| 836 |
DIARRHOEA |
180 |
0.0003 |
| 837 |
PRURITUS |
107 |
0.0003 |
| 838 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
8 |
0.0003 |
| 839 |
RASH PRURITIC |
15 |
0.0003 |
| 840 |
TOOTHACHE |
5 |
0.0003 |
| 841 |
GASTROINTESTINAL HAEMORRHAGE |
23 |
0.0003 |
| 842 |
LIVER FUNCTION TEST ABNORMAL |
8 |
0.0003 |
| 843 |
GASTROENTERITIS |
4 |
0.0003 |
| 844 |
NAUSEA |
216 |
0.0003 |
| 845 |
THERAPY CESSATION |
14 |
0.0003 |
| 846 |
ASCITES |
8 |
0.0003 |
| 847 |
PSYCHOTIC DISORDER |
8 |
0.0003 |
| 848 |
BLOOD GLUCOSE DECREASED |
13 |
0.0003 |
| 849 |
NO ADVERSE EVENT |
49 |
0.0003 |
| 850 |
FUNGAL INFECTION |
9 |
0.0003 |
| 851 |
PANCREATITIS ACUTE |
6 |
0.0003 |
| 852 |
ERYTHEMA |
54 |
0.0003 |
| 853 |
ABDOMINAL PAIN UPPER |
54 |
0.0003 |
| 854 |
HERPES ZOSTER |
15 |
0.0003 |
| 855 |
DRY EYE |
13 |
0.0003 |
| 856 |
LOWER LIMB FRACTURE |
5 |
0.0003 |
| 857 |
DELIRIUM |
9 |
0.0003 |
| 858 |
FREQUENT BOWEL MOVEMENTS |
7 |
0.0003 |
| 859 |
LIMB DISCOMFORT |
8 |
0.0003 |
| 860 |
HAEMORRHAGE |
27 |
0.0003 |
| 861 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
6 |
0.0003 |
| 862 |
EJECTION FRACTION DECREASED |
4 |
0.0003 |
| 863 |
BLOOD PRESSURE DECREASED |
17 |
0.0003 |
| 864 |
OEDEMA PERIPHERAL |
31 |
0.0003 |
| 865 |
SEPTIC SHOCK |
11 |
0.0003 |
| 866 |
CATARACT |
15 |
0.0003 |
| 867 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
9 |
0.0003 |
| 868 |
CYSTITIS |
8 |
0.0003 |
| 869 |
HEPATIC ENZYME INCREASED |
17 |
0.0002 |
| 870 |
OROPHARYNGEAL PAIN |
23 |
0.0002 |
| 871 |
CRYING |
9 |
0.0002 |
| 872 |
CHILLS |
29 |
0.0002 |
| 873 |
STOMATITIS |
15 |
0.0002 |
| 874 |
FLATULENCE |
14 |
0.0002 |
| 875 |
EXTRA DOSE ADMINISTERED |
10 |
0.0002 |
| 876 |
ANAEMIA |
47 |
0.0002 |
| 877 |
BODY TEMPERATURE INCREASED |
5 |
0.0002 |
| 878 |
IMPAIRED HEALING |
8 |
0.0002 |
| 879 |
AGEUSIA |
6 |
0.0002 |
| 880 |
HYPOTENSION |
48 |
0.0002 |
| 881 |
ADVERSE EVENT |
22 |
0.0002 |
| 882 |
DRUG RESISTANCE |
6 |
0.0002 |
| 883 |
INFLAMMATION |
12 |
0.0002 |
| 884 |
UNRESPONSIVE TO STIMULI |
6 |
0.0002 |
| 885 |
HEPATIC FAILURE |
7 |
0.0002 |
| 886 |
PYREXIA |
80 |
0.0002 |
| 887 |
HYPONATRAEMIA |
13 |
0.0002 |
| 888 |
VOMITING |
108 |
0.0002 |
| 889 |
URINARY TRACT INFECTION |
39 |
0.0002 |
| 890 |
DISORIENTATION |
9 |
0.0002 |
| 891 |
INJECTION SITE HAEMORRHAGE |
18 |
0.0002 |
| 892 |
SWOLLEN TONGUE |
7 |
0.0002 |
| 893 |
DRUG-INDUCED LIVER INJURY |
7 |
0.0002 |
| 894 |
RASH PAPULAR |
5 |
0.0002 |
| 895 |
THROAT IRRITATION |
10 |
0.0002 |
| 896 |
PAIN OF SKIN |
6 |
0.0002 |
| 897 |
DYSKINESIA |
9 |
0.0002 |
| 898 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
8 |
0.0002 |
| 899 |
MULTIPLE SCLEROSIS RELAPSE |
15 |
0.0002 |
| 900 |
RHINORRHOEA |
14 |
0.0002 |
| 901 |
BLOOD GLUCOSE ABNORMAL |
4 |
0.0002 |
| 902 |
ABDOMINAL PAIN |
50 |
0.0002 |
| 903 |
DEMENTIA |
6 |
0.0002 |
| 904 |
WOUND |
6 |
0.0002 |
| 905 |
SKIN EXFOLIATION |
18 |
0.0002 |
| 906 |
EYE DISORDER |
7 |
0.0002 |
| 907 |
HALLUCINATION |
16 |
0.0002 |
| 908 |
VISUAL ACUITY REDUCED |
7 |
0.0002 |
| 909 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 910 |
GASTRIC ULCER |
4 |
0.0002 |
| 911 |
LIP SWELLING |
7 |
0.0002 |
| 912 |
RED BLOOD CELL COUNT DECREASED |
6 |
0.0002 |
| 913 |
NEOPLASM MALIGNANT |
14 |
0.0002 |
| 914 |
GAIT INABILITY |
7 |
0.0002 |
| 915 |
EYE PRURITUS |
7 |
0.0002 |
| 916 |
BLOOD PRESSURE FLUCTUATION |
5 |
0.0002 |
| 917 |
DRUG PRESCRIBING ERROR |
4 |
0.0002 |
| 918 |
BRADYCARDIA |
11 |
0.0002 |
| 919 |
EAR PAIN |
4 |
0.0002 |
| 920 |
DRY SKIN |
27 |
0.0002 |
| 921 |
GASTROINTESTINAL DISORDER |
18 |
0.0002 |
| 922 |
RESPIRATORY DISORDER |
6 |
0.0002 |
| 923 |
PSORIASIS |
26 |
0.0002 |
| 924 |
JOINT SWELLING |
24 |
0.0002 |
| 925 |
ALOPECIA |
39 |
0.0002 |
| 926 |
MEDICATION ERROR |
11 |
0.0002 |
| 927 |
HYPOPHAGIA |
5 |
0.0002 |
| 928 |
RESTLESSNESS |
7 |
0.0002 |
| 929 |
JOINT STIFFNESS |
5 |
0.0002 |
| 930 |
GASTRITIS |
5 |
0.0002 |
| 931 |
EATING DISORDER |
4 |
0.0002 |
| 932 |
PLATELET COUNT DECREASED |
20 |
0.0002 |
| 933 |
DRUG INTOLERANCE |
18 |
0.0002 |
| 934 |
JAUNDICE |
5 |
0.0002 |
| 935 |
HYPOGLYCAEMIA |
9 |
0.0002 |
| 936 |
RHEUMATOID ARTHRITIS |
21 |
0.0002 |
| 937 |
COLITIS |
7 |
0.0002 |
| 938 |
DEVICE LEAKAGE |
8 |
0.0002 |
| 939 |
CLOSTRIDIUM DIFFICILE INFECTION |
4 |
0.0002 |
| 940 |
SUICIDE ATTEMPT |
11 |
0.0002 |
| 941 |
HAEMATOCHEZIA |
10 |
0.0002 |
| 942 |
INFUSION RELATED REACTION |
12 |
0.0002 |
| 943 |
FEBRILE NEUTROPENIA |
12 |
0.0002 |
| 944 |
OVERDOSE |
39 |
0.0002 |
| 945 |
HAEMOPTYSIS |
5 |
0.0002 |
| 946 |
COLITIS ULCERATIVE |
8 |
0.0002 |
| 947 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
6 |
0.0002 |
| 948 |
INTERNATIONAL NORMALISED RATIO INCREASED |
5 |
0.0002 |
| 949 |
WHITE BLOOD CELL COUNT DECREASED |
19 |
0.0002 |
| 950 |
DEVICE BREAKAGE |
7 |
0.0002 |
| 951 |
NEUTROPHIL COUNT DECREASED |
7 |
0.0002 |
| 952 |
DRUG WITHDRAWAL SYNDROME |
15 |
0.0002 |
| 953 |
THROMBOCYTOPENIA |
19 |
0.0002 |
| 954 |
ACCIDENTAL OVERDOSE |
6 |
0.0002 |
| 955 |
DRUG INTERACTION |
26 |
0.0002 |
| 956 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
4 |
0.0002 |
| 957 |
PANCYTOPENIA |
9 |
0.0002 |
| 958 |
DEVICE DISLOCATION |
7 |
0.0002 |
| 959 |
ABDOMINAL PAIN LOWER |
4 |
0.0002 |
| 960 |
LIVER DISORDER |
7 |
0.0002 |
| 961 |
DRUG DEPENDENCE |
25 |
0.0002 |
| 962 |
HIP FRACTURE |
5 |
0.0002 |
| 963 |
ANAPHYLACTIC SHOCK |
4 |
0.0002 |
| 964 |
SWELLING FACE |
10 |
0.0002 |
| 965 |
RASH ERYTHEMATOUS |
7 |
0.0001 |
| 966 |
MULTIPLE SCLEROSIS |
7 |
0.0001 |
| 967 |
LUNG NEOPLASM MALIGNANT |
6 |
0.0001 |
| 968 |
CONVULSION |
8 |
0.0001 |
| 969 |
HYPERGLYCAEMIA |
5 |
0.0001 |
| 970 |
DEATH |
116 |
0.0001 |
| 971 |
DEVICE ISSUE |
12 |
0.0001 |
| 972 |
FEMUR FRACTURE |
4 |
0.0001 |
| 973 |
DISEASE PROGRESSION |
14 |
0.0001 |
| 974 |
RENAL FAILURE ACUTE |
5 |
0.0001 |
| 975 |
NEUTROPENIA |
16 |
0.0001 |
| 976 |
HAEMOGLOBIN DECREASED |
12 |
0.0001 |
| 977 |
GASTRIC DISORDER |
4 |
0.0001 |
| 978 |
DEVICE USE ERROR |
4 |
0.0001 |
| 979 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
5 |
0.0001 |
| 980 |
COMA |
5 |
0.0001 |
| 981 |
BLADDER CANCER |
6 |
0.0001 |
| 982 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
4 |
0.0001 |
| 983 |
DEVICE MALFUNCTION |
7 |
0.0001 |
| 984 |
TREATMENT FAILURE |
8 |
0.0001 |
| 985 |
INTENTIONAL OVERDOSE |
6 |
0.0001 |
| 986 |
DEPENDENCE |
5 |
0.0001 |
| 987 |
COMPLETED SUICIDE |
7 |
0.0001 |
| 988 |
MALIGNANT NEOPLASM PROGRESSION |
8 |
0.0001 |
| 989 |
DRUG DOSE OMISSION BY DEVICE |
6 |
0.0001 |
| 990 |
BREAST CANCER |
7 |
0.0001 |
| 991 |
SKIN BURNING SENSATION |
5 |
0.0001 |
| 992 |
DEVICE DIFFICULT TO USE |
4 |
0.0001 |
| 993 |
TOXICITY TO VARIOUS AGENTS |
7 |
0.0000 |